Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOG

The expression of pluripotency factors is a key regulator of tumor differentiation status and cancer stem cells. The purpose of this study was to examine the expression of pluripotency factors and differentiation status of human mesothelioma and the role of mitochondria in their regulation. We teste...

Full description

Saved in:
Bibliographic Details
Main Authors: Filip Sedlic (Author), Fran Seiwerth (Author), Ana Sepac (Author), Suncana Sikiric (Author), Marina Cindric (Author), Marija Milavic (Author), Lovorka Batelja Vuletic (Author), Marko Jakopovic (Author), Sven Seiwerth (Author)
Format: Book
Published: MDPI AG, 2020-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_880ad434b57548c3b97c47f92e48eafa
042 |a dc 
100 1 0 |a Filip Sedlic  |e author 
700 1 0 |a Fran Seiwerth  |e author 
700 1 0 |a Ana Sepac  |e author 
700 1 0 |a Suncana Sikiric  |e author 
700 1 0 |a Marina Cindric  |e author 
700 1 0 |a Marija Milavic  |e author 
700 1 0 |a Lovorka Batelja Vuletic  |e author 
700 1 0 |a Marko Jakopovic  |e author 
700 1 0 |a Sven Seiwerth  |e author 
245 0 0 |a Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOG 
260 |b MDPI AG,   |c 2020-07-01T00:00:00Z. 
500 |a 10.3390/antiox9070606 
500 |a 2076-3921 
520 |a The expression of pluripotency factors is a key regulator of tumor differentiation status and cancer stem cells. The purpose of this study was to examine the expression of pluripotency factors and differentiation status of human mesothelioma and the role of mitochondria in their regulation. We tested the expression of OCT4/<i>POU5F1</i>, NANOG, SOX2, PI3K-AKT pathway and BCL2 genes and proteins in 65 samples of human mesothelioma and 19 samples of normal mesothelium. Mitochondrial membrane potential, reactive oxygen species (ROS) generation and expression of pluripotency factors were also tested in human mesothelioma cell line. Human mesothelium and mesothelioma expressed SOX2, NANOG, PI3K and AKT genes and proteins and <i>POU5F1</i> gene, whereby NANOG, SOX2 and phosphorylated (activated) AKT were upregulated in mesothelioma. NANOG protein expression was elevated in less differentiated samples of human mesothelioma. The expression of genes of PI3K-AKT pathway correlated with pluripotency factor genes. Mesothelioma cells had functional, but depolarized mitochondria with large capacity to generate ROS. Mitochondrial ROS upregulated NANOG and mitoTEMPO abrogated it. In conclusion, human mesothelioma displays enhanced expression of NANOG, SOX2 and phosphorylated AKT proteins, while elevated NANOG expression correlates with poor differentiation of human mesothelioma. Mitochondria of mesothelioma cells have a large capacity to form ROS and thereby upregulate NANOG, leading to dedifferentiation of mesothelioma. 
546 |a EN 
690 |a pluripotency factors 
690 |a reprogramming 
690 |a mesothelioma 
690 |a reactive oxygen species 
690 |a mitochondria 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 9, Iss 7, p 606 (2020) 
787 0 |n https://www.mdpi.com/2076-3921/9/7/606 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/880ad434b57548c3b97c47f92e48eafa  |z Connect to this object online.